Effect of biologic therapy on radiological progression in rheumatoid arthritis: what does it add to methotrexate?

Graeme Jones, Erica Darian-Smith, Michael Kwok, Tania WinzenbergMenzies Research Institute, University of Tasmania, Tasmania, AustraliaAbstract: There have been substantial advances in the treatment of rheumatoid arthritis in recent years. Traditional disease-modifying antirheumatic drugs (DMARDs) h...

Full description

Bibliographic Details
Main Authors: Jones G, Darian-Smith E, Kwok M, Winzenberg T
Format: Article
Language:English
Published: Dove Medical Press 2012-07-01
Series:Biologics: Targets & Therapy
Online Access:http://www.dovepress.com/effect-of-biologic-therapy-on-radiological-progression-in-rheumatoid-a-a10281
_version_ 1818845143774527488
author Jones G
Darian-Smith E
Kwok M
Winzenberg T
author_facet Jones G
Darian-Smith E
Kwok M
Winzenberg T
author_sort Jones G
collection DOAJ
description Graeme Jones, Erica Darian-Smith, Michael Kwok, Tania WinzenbergMenzies Research Institute, University of Tasmania, Tasmania, AustraliaAbstract: There have been substantial advances in the treatment of rheumatoid arthritis in recent years. Traditional disease-modifying antirheumatic drugs (DMARDs) have been shown to have small effects on the progression of radiographic damage. This quantitative overview summarizes the evidence for biologic DMARDS and radiographic damage either alone or in combination with methotrexate. Two outcomes were used (standardized mean difference and odds of progression). A total of 21 trials were identified of which 18 had useable data. For biologic monotherapy, tocilizumab, adalimumab, and etanercept were significantly better than methotrexate, with tocilizumab ranking first in both outcomes while golimumab was ineffective in both outcomes. For a biologic in combination with methotrexate compared with methotrexate alone, most therapies studied (etanercept, adalimumab, infliximab, certolizumab, tocilizumab, and rituximab) were effective at slowing X-ray progression using either outcome, with infliximab ranking first in both outcomes. The exceptions to this were golimumab (no effect on standardized mean difference) and abatacept (no effect on odds of progression). This effect was additional to methotrexate; thus, the overall benefit is moderate to large in magnitude, which is clearly of major clinical significance for sufferers of rheumatoid arthritis and supports the use of biologic DMARDs in those with a poor disease prognosis.Keywords: rheumatoid, trials, meta-analysis, radiographs, biologic, disease-modifying antirheumatic drugs, DMARDs
first_indexed 2024-12-19T05:24:59Z
format Article
id doaj.art-eaa164dc94464baa9bc2ed68996b4070
institution Directory Open Access Journal
issn 1177-5475
1177-5491
language English
last_indexed 2024-12-19T05:24:59Z
publishDate 2012-07-01
publisher Dove Medical Press
record_format Article
series Biologics: Targets & Therapy
spelling doaj.art-eaa164dc94464baa9bc2ed68996b40702022-12-21T20:34:24ZengDove Medical PressBiologics: Targets & Therapy1177-54751177-54912012-07-012012default155161Effect of biologic therapy on radiological progression in rheumatoid arthritis: what does it add to methotrexate?Jones GDarian-Smith EKwok MWinzenberg TGraeme Jones, Erica Darian-Smith, Michael Kwok, Tania WinzenbergMenzies Research Institute, University of Tasmania, Tasmania, AustraliaAbstract: There have been substantial advances in the treatment of rheumatoid arthritis in recent years. Traditional disease-modifying antirheumatic drugs (DMARDs) have been shown to have small effects on the progression of radiographic damage. This quantitative overview summarizes the evidence for biologic DMARDS and radiographic damage either alone or in combination with methotrexate. Two outcomes were used (standardized mean difference and odds of progression). A total of 21 trials were identified of which 18 had useable data. For biologic monotherapy, tocilizumab, adalimumab, and etanercept were significantly better than methotrexate, with tocilizumab ranking first in both outcomes while golimumab was ineffective in both outcomes. For a biologic in combination with methotrexate compared with methotrexate alone, most therapies studied (etanercept, adalimumab, infliximab, certolizumab, tocilizumab, and rituximab) were effective at slowing X-ray progression using either outcome, with infliximab ranking first in both outcomes. The exceptions to this were golimumab (no effect on standardized mean difference) and abatacept (no effect on odds of progression). This effect was additional to methotrexate; thus, the overall benefit is moderate to large in magnitude, which is clearly of major clinical significance for sufferers of rheumatoid arthritis and supports the use of biologic DMARDs in those with a poor disease prognosis.Keywords: rheumatoid, trials, meta-analysis, radiographs, biologic, disease-modifying antirheumatic drugs, DMARDshttp://www.dovepress.com/effect-of-biologic-therapy-on-radiological-progression-in-rheumatoid-a-a10281
spellingShingle Jones G
Darian-Smith E
Kwok M
Winzenberg T
Effect of biologic therapy on radiological progression in rheumatoid arthritis: what does it add to methotrexate?
Biologics: Targets & Therapy
title Effect of biologic therapy on radiological progression in rheumatoid arthritis: what does it add to methotrexate?
title_full Effect of biologic therapy on radiological progression in rheumatoid arthritis: what does it add to methotrexate?
title_fullStr Effect of biologic therapy on radiological progression in rheumatoid arthritis: what does it add to methotrexate?
title_full_unstemmed Effect of biologic therapy on radiological progression in rheumatoid arthritis: what does it add to methotrexate?
title_short Effect of biologic therapy on radiological progression in rheumatoid arthritis: what does it add to methotrexate?
title_sort effect of biologic therapy on radiological progression in rheumatoid arthritis what does it add to methotrexate
url http://www.dovepress.com/effect-of-biologic-therapy-on-radiological-progression-in-rheumatoid-a-a10281
work_keys_str_mv AT jonesg effectofbiologictherapyonradiologicalprogressioninrheumatoidarthritiswhatdoesitaddtomethotrexate
AT dariansmithe effectofbiologictherapyonradiologicalprogressioninrheumatoidarthritiswhatdoesitaddtomethotrexate
AT kwokm effectofbiologictherapyonradiologicalprogressioninrheumatoidarthritiswhatdoesitaddtomethotrexate
AT winzenbergt effectofbiologictherapyonradiologicalprogressioninrheumatoidarthritiswhatdoesitaddtomethotrexate